This disclosure relates to: (a) compounds and salts thereof that, inter alia, inhibit RSV infection and/or replication； (b) intermediates useful for the preparation of such compounds and salts； (c) compositions comprising such compounds and salts； (d) methods for preparing such intermediates, compounds, salts, and compositions； (e) methods of use of such compounds, salts, and compositions； and (f) kits comprising such compounds, salts, and compositions.
